Vertex Pharmaceuticals Incorporated - Common Stock
VRTX US產業類別: Biotechnology · 資料基準日: 2026-11-05
最新收盤價
549.0399780273438
時序基礎模型目標價
549.7129516601562
預期潛力: +0.12%
本益比 / 股價淨值比 (PE / PB)
35.330757 / 6.6576123
歷史估值分位水位
季線 MA60 / 半年線 MA120
N/A / N/A
關鍵中期支撐均線
近 5 日外資與投信籌碼
0 張
三大法人籌碼淨流向
info 公司基本業務與營運簡述
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfus
hub 相關同業與供應鏈推薦 (Peers)
AAAP
US
Pacer Barings CLO Market Flex ETF
現價: N/A
AACG
US
ATA Creativity Global - American Depositary Shares, each representing two common shares
現價: N/A
AACI
US
Armada Acquisition Corp. III - Class A Ordinary Share
現價: N/A
AACIU
US
Armada Acquisition Corp. III - Units
現價: N/A
AACIW
US
Armada Acquisition Corp. III - Warrant
現價: N/A
AACO
US
Abony Acquisition Corp. I - Class A Ordinary Share
現價: N/A
想檢視 Vertex Pharmaceuticals Incorporated - Common Stock 的完整時序大模型預測與法說會情報？
888 StockQuant 提供 TimesFM、Timestral 與 MOIRAI 三大時序模型共振分析、法人分點買賣超與即時推播告警。